Showing results (351-360 of 402) with videos related to
Sort By:
Pageof 41
Journal of Clinical Gastroenterology|October 1, 1995
Clinicopathologic characteristics of Helicobacter pyloric seropositive gastric adenocarcinomasW J Lee, J T Lin, W C Lee, et al.Cancer Research|January 15, 1987
Phase I studies with trimetrexate: clinical pharmacology, analytical methodology, and pharmacokineticsJ T Lin, A R Cashmore, M Baker, et al.Journal of Gastroenterology and Hepatology|May 7, 1998
Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stagesM S Wu, C T Shun, J C Sheu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomachL T Chen, J T Lin, R Y Shyu, et al.Alimentary Pharmacology & Therapeutics|December 17, 2015
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infectionJ-M Liou, C-C Chen, Y-C Lee, et al.Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 16, 2021
[Human bone marrow mesenchymal stem cells improve steroid resistance of human airway epithelial BEAS-2B cells in vitro]C X Li, J T Lin, Q Zhang, et al.Zhonghua Nei Ke Za Zhi|July 11, 2017
[Chinese expert consensus for non-antiinfective effects and clinical use of macrolides]J T Lin, Y M Zhang, X Zhou, et al.The New England Journal of Medicine|November 8, 1990
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein BG Brown, J J Albers, L D Fisher, et al.Gastroenterology|June 1, 1995
Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term studyH C Weber, D J Venzon, J T Lin, et al.Gut|October 22, 2008
The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux diseaseY-C Lee, A M-F Yen, J J Tai, et al.Pageof 41